Category: Include on Menu
-
Viatris Agrees to Acquire Pacira BioSciences for $1.65 Billion in Non-Opioid Pain Therapy Expansion
The $36.50-per-share cash acquisition adds two established pain treatments to Viatris’ portfolio and is expected to contribute immediately to its financial guidance metrics following completion by the end of 2026. Key Investor Takeaways Why VTRS and PCRX Stocks Are in Focus Viatris has entered into a definitive agreement to purchase all outstanding shares of Pacira…
-
argenx Reports Positive Phase 2 Celiac Disease Trial Results, Plans Phase 3 Development of FB102
argenx’s experimental CD122 inhibitor met its primary endpoint in a 126-patient study, demonstrating protection against gluten-induced intestinal damage and supporting advancement into late-stage clinical development. Key Investor Takeaways Why ARGX Stock Is in Focus argenx has reported positive topline results from its randomized, double-blind, placebo-controlled Phase 2 FB102-301 study evaluating FB102 in adults with celiac…
-
bioAffinity Technologies Receives Japanese Patent Allowance for CyPath Lung AI Diagnostic Test
The Japanese Patent Office has signalled its intention to grant patent protection for bioAffinity Technologies’ noninvasive lung cancer detection technology, expanding the company’s intellectual property coverage in Asia. Key Investor Takeaways Why BIAF Stock Is in Focus bioAffinity Technologies has received a Notice of Allowance from the Japan Patent Office for its patent application titled…
-
FingerMotion Initiates Offtake Discussions for 9.9 MW Alberta Data Center Campus
FingerMotion is seeking long-term capacity agreements for Brooks Campus #1, with powered land expected to become available in early 2027 as the company advances its broader 99 MW computing infrastructure program. Key Investor Takeaways Why FNGR Stock Is in Focus FingerMotion has initiated commercial discussions for Brooks Campus #1, a planned 9.9 megawatt behind-the-meter power…
-
US Initial Jobless Claims Unexpectedly Fall to 197,000, Below Economists’ Forecasts
Initial claims for unemployment benefits in the United States unexpectedly declined in the week ended 3 October, according to figures released by the US Department of Labor on Thursday, indicating that applications for unemployment assistance remained relatively low. The report showed that first-time jobless claims fell by 2,000 to 197,000, compared with an upwardly revised…
-
Wall Street Futures Decline as Oil Prices Surge on Renewed Iran Conflict Concerns: Dow Jones, S&P, Nasdaq
US stock futures pointed to a weaker opening on Thursday as a sharp rebound in crude oil prices raised concerns about escalating tensions in the Middle East, persistent inflation and the possibility of further interest rate increases. US crude oil futures climbed nearly 5%, while Brent crude moved back above $100 a barrel following reports…
-
SolarEdge Appoints Former Enphase Executive Gokul Krishnan to Lead North American Operations
SolarEdge Technologies (NASDAQ:SEDG) has appointed Gokul Krishnan as Senior Vice President and General Manager of North America, strengthening its regional leadership as the solar technology company seeks to expand adoption of its next-generation energy solutions. Krishnan, who is based in California, has already assumed his responsibilities and will oversee SolarEdge’s operations across the North American…
-
Hyperfine Reports Record Preliminary Q3 Revenue of $6 Million, Up 53% Sequentially
Hyperfine, Inc. (NASDAQ:HYPR) has reported preliminary third-quarter 2026 revenue of approximately $6.0 million, representing a 53% increase from the previous quarter and marking a record quarterly performance for the medical device manufacturer. The Connecticut-based company also reported a reduction in cash consumption, with preliminary net cash burn, excluding financing proceeds, expected to reach approximately $5.6…
-
Microchip Technology Introduces MTCH3380P and MTCH3240P Touch Controllers With Parallel Sensing
Microchip Technology (NASDAQ:MCHP) has launched two capacitive-touch controllers, the MTCH3380P and MTCH3240P, designed to improve touch responsiveness and simplify the development of user interfaces for consumer, commercial and industrial equipment. The company said the devices are the first in its turnkey touch-controller portfolio to incorporate parallel sensing technology for buttons, sliders and wheels. Both controllers…
-
X4 Pharmaceuticals Secures Up to $150 Million in New Debt Financing From K2 HealthVentures
X4 Pharmaceuticals (NASDAQ:XFOR) has entered into a senior secured term loan agreement worth up to $150 million with K2 HealthVentures LLC, refinancing its existing debt facility and providing additional financial flexibility as the biotechnology company advances its clinical development and commercialisation plans. The Boston-based company confirmed that an initial $80 million tranche was funded upon…